Diseases, Conditions, Syndromes
New trial finds arthritis drug tocilizumab no better than standard care for severe COVID-19
Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical COVID-19 is no better than standard care alone in improving clinical outcomes at 15 days, finds a new trial published ...
6 hours ago
0
44
